|
|
Effect of Modified Duhuo Jisheng Decoction combined with Celecoxib in the treatment of knee osteoarthritis |
XIAO Qiang1 GUO Zilong1 XU Ningning2 |
1.Department of Orthopaedics, the First Hospital of Zhangjiakou City, Hebei Province, Zhangjiakou 075041, China;
2.Department of Pharmacy, the First Hospital of Zhangjiakou City, Hebei Province, Zhangjiakou 075041, China |
|
|
Abstract Objective To investigate the effect of Modified Duhuo Jisheng Decoction combined with Celecoxib in the treatment of knee osteoarthritis (KOA). Methods One hundred and nine patients with KOA admitted to the First Hospital of Zhangjiakou City from October 2016 to August 2019 were selected, they were divided into control group (n = 54) and study group (n = 55) according to random number table method. Control group was treated with Celecoxib Capsules and study group was treated with Modified Duhuo Jisheng Decoction. After 30 days of treatment, clinical efficacy, pain status, knee joint function and related cytokines of two groups were compared. The occurrence of adverse reactions during treatment of two groups was recorded. Results Total clinical effective rate of study group was higher than that of control group (P < 0.05). After 30 days of treatment, VAS score of two groups was lower than that before treatment, while the knee joint function score was higher than that before treatment (P < 0.05). After 30 days of treatment, VAS score of study group was lower than that of control group and the knee joint function score was higher than that of control group (P < 0.05). After 30 days of treatment, the levels of IL-1β, IL-6, MMP-3 and SOD in two groups were lower than those before treatment (P < 0.05). After 30 days of treatment, the levels of IL-1β, IL-6, MMP-3 and SOD in study group were lower than those in control group (P < 0.05). There was no significant difference in the incidence of adverse reactions between two groups (P > 0.05). Conclusion The effect of Modified Duhuo Jisheng Decoction in the treatment of KOA is definite, which can effectively improve clinical symptoms and knee joint function of patients. The main mechanism may be caused by improving related cytokines.
|
|
|
|
|
[1] Jadon A,Jain P,Motaka M,et al. Comparative evaluation of monopolar and bipolar radiofrequency ablation of genicular nerves in chronic knee pain due to osteoarthritis [J]. Indian J Anaesth,2018,62(11):876-880.
[2] 郑斌,梅伟,魏成建,等.中医治疗膝骨关节炎研究进展[J].湖北中医药大学学报,2016,18(2):114-117.
[3] 许辉,康冰心,孙松涛,等.膝关节骨性关节炎的中医临床研究进展[J].中医学报,2019,34(10):2124-2129.
[4] 李新,付立新,张书钦.加味独活寄生汤联合关节镜下清理术治疗膝骨关节炎54例临床研究[J].四川中医,2017, 35(2):141-143.
[5] Brown GA. AAOS clinical practice guideline:treatment of osteoarthritis of the knee:evidence-based guideline,2nd edition [J]. J Am Acad Orthop Surg,2013,21(9):577-579.
[6] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:48.
[7] 祝震亚,童蕾.独活寄生颗粒剂辨证加减治疗跟痛症89例[J].浙江中西医结合杂志,2016,26(1):80-81.
[8] 王健,许翠平.负荷控制下的本体感觉训练在膝骨性关节炎中的应用[J].中国临床研究,2015,28(12):1621-1623.
[9] 潘雪璟,王伟钢.膝骨关节炎的中医研究进展[J].风湿病与关节炎,2016,5(12):74-77.
[10] 王朝旭,孙宝巍,兰阿勇,等.膝骨关节炎中医研究现状[J].河北中医,2019,41(8):1261-1266.
[11] 王爱国,吕佳康,谷福顺,等.中医中药治疗膝骨关节炎的新药研究及评价[J].中国临床药理学杂志,2017,33(16):1610-1612.
[12] 齐晓凤,王腾腾,梁倩倩,等.膝骨关节炎中医证型的研究现状[J].世界科学技术-中医药现代化,2016,18(11):1879-1882.
[13] 周敦颐,吴同适,张学连.独活寄生汤配合中医康复治疗膝关节骨性关节炎的临床效果[J].临床合理用药杂志,2019,12(32):70-72.
[14] 姜兆松,廖广军,袁春荣.独活寄生汤加减联合中医骨伤手法治疗腰椎间盘突出症的疗效观察[J].世界中西医结合杂志,2019,14(12):1750-1752,1767.
[15] 吴广文,刘淑如,陈俊,等.独活寄生汤治疗膝骨关节炎的作用机制[J].中国组织工程研究,2019,23(19):2965-2971.
[16] 贾维东.独活寄生汤加减联合针灸治疗膝关节骨性关节炎临床研究[J].河南中医,2019,39(11):1743-1746.
[17] Dai Z,Jafarzadeh SR,Niu J,et al. Body mass index mediates the association between dietary fiber and symptomatic knee osteoarthritis in the osteoarthritis initiative and the framingham osteoarthritis study [J]. J Nutr,2018,148(12):1961-1967.
[18] 王武炼,林煜,张怡元,等.独活寄生汤含药血清对退变软骨细胞细胞色素C及pro-Caspase-9、3的影响[J].中国组织工程研究,2015,19(33):5269-5273.
[19] 陈长凯,叶宝飞,张志伟,等.电针联合独活寄生丸治疗老年膝骨关节炎的疗效及对炎性因子的影响[J].实用老年医学,2019,33(9):884-887,891.
[20] 陈巧玉,周鑫,扶世杰,等.独活寄生汤干预食蟹猴自发性膝骨关节炎模型炎症的作用[J].中国组织工程研究,2018,22(12):1866-1871.
[21] 张立源,宋鹏程,宋雪,等.自拟独活寄生汤治疗腰椎间盘突出症椎间孔镜术后的感觉异常[J].国际中医中药杂志,2018,40(12):1138-1141. |
|
|
|